The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency
Open accessAbstract
The wide range of phenotypic abnormalities seen in the leptin-deficient ob/ob mouse and their reversibility by leptin administration provide compelling evidence for the existence of multiple physiological functions of this hormone in rodents. In contrast, information regarding the roles of this hormone in humans is limited. Three morbidly obese children, who were congenitally deficient in leptin, were treated with daily subcutaneous injections of recombinant human leptin for up to 4 years with sustained, beneficial effects on appetite, fat mass, hyperinsulinemia, and hyperlipidemia. Leptin therapy resulted in a rapid and sustained increase in plasma thyroid hormone levels and, through its age-dependent effects on gonadotropin secretion, facilitated appropriately timed pubertal development. Leptin deficiency was associated with reduced numbers of circulating CD4(+) T cells and impaired T cell proliferation and cytokine release, all of which were reversed by recombinant human leptin administration. The subcutaneous administration of recombinant human leptin has major and sustained beneficial effects on the multiple phenotypic abnormalities associated with congenital human leptin deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995) · Science · doi:10.1126/science.7624778 · Cited by 3,243
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Congenital leptin deficiency is associated with severe early-onset obesity in humans
Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., Sewter, C. P., Digby, J. E., Mohammed, S. N., Hurst, J. A., et al. (1997) · Nature · doi:10.1038/43185 · Cited by 2,936
Self-citationA mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Physical growth: National Center for Health Statistics percentiles
Hamill, P. V. V., Drizd, T., Johnson, C., Reed, R., Roche, A., & Moore, W. (1979) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/32.3.607 · Cited by 2,323
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R., & Lechler, R. I. (1998) · Nature · doi:10.1038/29795 · Cited by 2,160
Self-citationEffects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998
Self-citation
Research works printed but not linked: 3
- Ohtake, 1977, Am J Physiol, 233, 110
- Murgatroyd, 1993, Int J Obes Relat Metab Disord, 17, 549
- 10.1210/jc.84.10.3686 · doi:10.1210/jc.84.10.3686 · Paper page
Cited by
Items 101–189 of 189
Leptin resistance: underlying mechanisms and diagnosis
Gruzdeva, O., Borodkina, D., Uchasova, E., Dyleva, Y., & Barbarash, O. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s182406 · Cited by 299
Feeding Our Immune System: Impact on Metabolism
Wolowczuk, I., Verwaerde, C., Viltart, O., Delanoye, A., Delacre, M., Pot, B., & Grangette, C. (2008) · Clinical and Developmental Immunology · doi:10.1155/2008/639803 · Cited by 297
Leptin revisited: its mechanism of action and potential for treating diabetes
Coppari, R., & Bjørbæk, C. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3757 · Cited by 293
Leptin is an effective treatment for hypothalamic amenorrhea
Chou, S. H., Chamberland, J. P., Liu, X., Matarese, G., Gao, C., Stefanakis, R., Brinkoetter, M. T., Gong, H., Arampatzi, K., & Mantzoros, C. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015674108 · Cited by 287
Self-citationMutations in ligands and receptors of the leptin–melanocortin pathway that lead to obesity
Farooqi, I. S., & O'Rahilly, S. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0966 · Cited by 291
Self-citationSpeakman, J. R., Levitsky, D. A., Allison, D. B., Bray, M. S., de Castro, J. M., Clegg, D. J., Clapham, J. C., Dulloo, A. G., Gruer, L., Haw, S., et al. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.008698 · Cited by 290
Self-citationLeptin in human physiology and therapeutics
Dardeno, T. A., Chou, S. H., Moon, H.-S., Chamberland, J. P., Fiorenza, C. G., & Mantzoros, C. S. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.06.002 · Cited by 286
Genetic identification of leptin neural circuits in energy and glucose homeostases
Xu, J., Bartolome, C. L., Low, C. S., Yi, X., Chien, C.-H., Wang, P., & Kong, D. (2018) · Nature · doi:10.1038/s41586-018-0049-7 · Cited by 283
Qureshi, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i26.3540 · Cited by 283
Leptin Metabolically Licenses T Cells for Activation To Link Nutrition and Immunity
Saucillo, D. C., Gerriets, V. A., Sheng, J., Rathmell, J. C., & MacIver, N. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301158 · Cited by 282
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Hedbacker, K., Birsoy, K., Wysocki, R. W., Asilmaz, E., Ahima, R. S., Farooqi, I. S., & Friedman, J. M. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2009.11.007 · Cited by 280
Self-citationCytokines and abnormal glucose and lipid metabolism
Shi, J., Fan, J., Su, Q., & Yang, Z. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00703 · Cited by 282
“Consistent with mice studies, administration of recombinant leptin effectively improved metabolic disorders in patients with lipodystrophy or congenital leptin deficiency (154, 155).”
BackgroundRare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016
Huvenne, H., Dubern, B., Clément, K., & Poitou, C. (2016) · Obesity Facts · doi:10.1159/000445061 · Cited by 279
Gibson, W. T., Farooqi, I. S., Moreau, M., DePaoli, A. M., Lawrence, E., O’Rahilly, S., & Trussell, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0376 · Cited by 275
“Dosage calculation and monitoring were conducted as previously reported (4) with leptin administered sc once daily at 0800 h.”
BackgroundMethodResultInfluentialSelf-citationLaboratory animals as surrogate models of human obesity
Nilsson, C., Raun, K., Yan, F.-F., Larsen, M. O., & Tang-Christensen, M. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.203 · Cited by 275
Adipokines – removing road blocks to obesity and diabetes therapy
Blüher, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.005 · Cited by 273
Leptin as a key regulator of the adipose organ
Picó, C., Palou, M., Pomar, C. A., Rodríguez, A. M., & Palou, A. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09687-5 · Cited by 273
Leptin at 14 y of age: an ongoing story
Friedman, J. M. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26788b · Cited by 272
Obesity – is it a genetic disorder?
Loos, R. J. F., & Bouchard, C. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01242.x · Cited by 270
The role of leptin in regulating bone metabolism
Upadhyay, J., Farr, O. M., & Mantzoros, C. S. (2015) · Metabolism · doi:10.1016/j.metabol.2014.10.021 · Cited by 268
Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism
Zhang, E. E., Chapeau, E., Hagihara, K., & Feng, G.-S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405041101 · Cited by 266
Montonen, J., Järvinen, R., Knekt, P., Heliövaara, M., & Reunanen, A. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1447 · Cited by 265
Energy Homeostasis, Obesity and Eating Disorders: Recent Advances in Endocrinology
Gale, S. M., Castracane, V. D., & Mantzoros, C. S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.2.295 · Cited by 265
Adolescent Obesity and Puberty: The “Perfect Storm”
Jasik, C. B., & Lustig, R. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.009 · Cited by 264
Recinella, L., Orlando, G., Ferrante, C., Chiavaroli, A., Brunetti, L., & Leone, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.578966 · Cited by 261
Shore, S. A., & Johnston, R. A. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.002 · Cited by 262
Towards a pro-inflammatory and immunomodulatory emerging role of leptin
Otero, M., Lago, R., Gomez, R., Dieguez, C., Lago, F., Gómez-Reino, J., & Gualillo, O. (2006) · Rheumatology · doi:10.1093/rheumatology/kel157 · Cited by 260
Mind versus metabolism in the control of food intake and energy balance
BERTHOUD, H. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.04.034 · Cited by 259
The adipocyte as an active participant in energy balance and metabolism
Badman, M. K., & Flier, J. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.058 · Cited by 256
Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals
Moon, H.-S., Dalamaga, M., Kim, S.-Y., Polyzos, S. A., Hamnvik, O.-P., Magkos, F., Paruthi, J., & Mantzoros, C. S. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1053 · Cited by 258
Role of Adipose Tissue as an Inflammatory Organ in Human Diseases
Schäffler, A., Müller-Ladner, U., Schölmerich, J., & Büchler, C. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0022 · Cited by 258
Santini, F., Marzullo, P., Rotondi, M., Ceccarini, G., Pagano, L., Ippolito, S., Chiovato, L., & Biondi, B. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0067 · Cited by 240
Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans.
Chan, J. L., Matarese, G., Shetty, G. K., Raciti, P., Kelesidis, I., Aufiero, D., De Rosa, V., Perna, F., Fontana, S., & Mantzoros, C. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505429103 · Cited by 213
Self-citationLeptin replacement alters brain response to food cues in genetically leptin-deficient adults.
Baicy, K., London, E. D., Monterosso, J., Wong, M.-L., Delibasi, T., Sharma, A., & Licinio, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706481104 · Cited by 212
O'Rahilly, S., & Farooqi, I. S. (2008) · Diabetes · doi:10.2337/db08-0210 · Cited by 205
Self-citationLeptin in humans: lessons from translational research
Blüher, S., & Mantzoros, C. S. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26788e · Cited by 203
Anti-obesity therapy: from rainbow pills to polyagonists
Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199
European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
Pasquali, R., Casanueva, F., Haluzik, M., van Hulsteijn, L., Ledoux, S., Monteiro, M. P., Salvador, J., Santini, F., Toplak, H., & Dekkers, O. M. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0893 · Cited by 188
Burcelin, R., Thorens, B., Glauser, M., Gaillard, R. C., & Pralong, F. P. (2003) · Endocrinology · doi:10.1210/en.2003-0457 · Cited by 173
Unraveling the Genetics of Human Obesity
Mutch, D. M., & Clément, K. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020188 · Cited by 169
“Leptin therapy in children deficient in this adipokine dramatically reduced body weight, and was accompanied, in some instances, by improved insulinemia and pubertal development [31].”
BackgroundEvolutionary perspectives on the obesity epidemic: adaptive, maladaptive, and neutral viewpoints
Speakman, J. R. (2013) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150711 · Cited by 163
STUBBS, R., & WHYBROW, S. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.04.027 · Cited by 158
The macronutrients, appetite, and energy intake
Carreiro, A. L., Dhillon, J., Gordon, S., Higgins, K. A., Jacobs, A. G., McArthur, B. M., Redan, B. W., Rivera, R. L., Schmidt, L. R., & Mattes, R. D. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-121415-112624 · Cited by 159
Müller, T. D., Sullivan, L. M., Habegger, K., Yi, C., Kabra, D., Grant, E., Ottaway, N., Krishna, R., Holland, J., Hembree, J., et al. (2012) · Journal of Peptide Science · doi:10.1002/psc.2408 · Cited by 156
Martinelli, C. E., Keogh, J. M., Greenfield, J. R., Henning, E., van der Klaauw, A. A., Blackwood, A., O'Rahilly, S., Roelfsema, F., Camacho-Hübner, C., Pijl, H., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1369 · Cited by 153
Self-citationBrain Adipocytokine Action and Metabolic Regulation
Ahima, R. S., Qi, Y., Singhal, N. S., Jackson, M. B., & Scherer, P. E. (2006) · Diabetes · doi:10.2337/db06-s018 · Cited by 150
Musso, C., Cochran, E., Javor, E., Young, J., DePaoli, A. M., & Gorden, P. (2005) · Metabolism · doi:10.1016/j.metabol.2004.08.021 · Cited by 146
“The first is congenital leptin deficiency, characterized by obesity, where leptin intervention induces satiety and marked weight reduction [4].”
BackgroundSelf-citationZelissen, P. M. J., Stenlof, K., Lean, M. E. J., Fogteloo, J., Keulen, E. T. P., Wilding, J., Finer, N., Rössner, S., Lawrence, E., Fletcher, C., et al. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00468.x · Cited by 144
Self-citationEnergy intake in weight-reduced humans
Rosenbaum, M., Kissileff, H. R., Mayer, L. E. S., Hirsch, J., & Leibel, R. L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.062 · Cited by 142
Abbenhardt, C., McTiernan, A., Alfano, C. M., Wener, M. H., Campbell, K. L., Duggan, C., Foster‐Schubert, K. E., Kong, A., Toriola, A. T., Potter, J. D., et al. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12062 · Cited by 137
LRb-STAT3 Signaling Is Required for the Neuroendocrine Regulation of Energy Expenditure by Leptin
Bates, S. H., Dundon, T. A., Seifert, M., Carlson, M., Maratos-Flier, E., & Myers, M. G. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3067 · Cited by 139
Latest approaches for the treatment of obesity
Jackson, V. M., Breen, D. M., Fortin, J.-P., Liou, A., Kuzmiski, J. B., Loomis, A. K., Rives, M.-L., Shah, B., & Carpino, P. A. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1044966 · Cited by 132
McDuffie, J. R., Riggs, P. A., Calis, K. A., Freedman, R. J., Oral, E. A., DePaoli, A. M., & Yanovski, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031868 · Cited by 129
Self-citationLeptin and the Proinflammatory State Associated with Human Obesity
Hukshorn, C. J., Lindeman, J. H. N., Toet, K. H., Saris, W. H. M., Eilers, P. H. C., Westerterp-Plantenga, M. S., & Kooistra, T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030803 · Cited by 127
The efficiency of cellular energy transduction and its implications for obesity
Harper, M.-E., Green, K., & Brand, M. D. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155357 · Cited by 121
Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction
Thakker, G. D., Frangogiannis, N. G., Bujak, M., Zymek, P., Gaubatz, J. W., Reddy, A. K., Taffet, G., Michael, L. H., Entman, M. L., & Ballantyne, C. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00322.2006 · Cited by 121
“Furthermore, the pathology in genetic models of obesity develops in combination with several other abnormalities (18).”
BackgroundJavor, E. D., Moran, S. A., Young, J. R., Cochran, E. K., DePaoli, A. M., Oral, E. A., Turman, M. A., Blackett, P. R., Savage, D. B., O’Rahilly, S., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032140 · Cited by 114
Self-citationSavino, W., & Dardenne, M. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665110002545 · Cited by 109
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits
Hinney, A., Körner, A., & Fischer-Posovszky, P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00716-0 · Cited by 101
Changes in body composition in patients with severe lipodystrophy after leptin replacement therapy
Moran, S. A., Patten, N., Young, J. R., Cochran, E., Sebring, N., Reynolds, J., Premkumar, A., Depaoli, A. M., Skarulis, M. C., Oral, E. A., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.019 · Cited by 96
Self-citationHakim, F., Wang, Y., Carreras, A., Hirotsu, C., Zhang, J., Peris, E., & Gozal, D. (2015) · Sleep · doi:10.5665/sleep.4320 · Cited by 90
Mast Cells in Allergic and Inflammatory Diseases
Sismanopoulos, N., Delivanis, D.-A., Alysandratos, K.-D., Angelidou, A., Therianou, A., Kalogeromitros, D., & C. Theoharides, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800165997 · Cited by 87
20 YEARS OF LEPTIN: Leptin in common obesity and associated disorders of metabolism
DePaoli, A. M. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0258 · Cited by 86
Self-citationSexually different actions of leptin in proopiomelanocortin neurons to regulate glucose homeostasis
Shi, H., Strader, A. D., Sorrell, J. E., Chambers, J. B., Woods, S. C., & Seeley, R. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00704.2007 · Cited by 85
Hyperleptinemia: Protecting the Heart From Lipid Overload
Unger, R. H. (2005) · Hypertension · doi:10.1161/01.hyp.0000165683.09053.02 · Cited by 85
The role of leptin-->STAT3 signaling in neuroendocrine function: an integrative perspective
Bates, S. H., & Myers, M. G. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0494-z · Cited by 81
“Indeed, while some data suggest a direct role for leptin on TRH neurons, many data point to a critical role for aMSH and NPY projections from the ARC in the regulation of TRH [ 17 , 72, 73].”
BackgroundInfluentialPerello, M., Çakir, I., Cyr, N. E., Romero, A., Stuart, R. C., Chiappini, F., Hollenberg, A. N., & Nillni, E. A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00448.2010 · Cited by 80
Insulin and NPY pathways and the control of GnRH function and puberty onset
Pralong, F. P. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.01.037 · Cited by 78
Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy
Chan, J. L., Koda, J., Heilig, J. S., Cochran, E. K., Gorden, P., Oral, E. A., & Brown, R. J. (2016) · Clinical Endocrinology · doi:10.1111/cen.12980 · Cited by 72
von Schnurbein, J., Moss, A., Nagel, S. A., Muehleder, H., Debatin, K. M., Farooqi, I. S., & Wabitsch, M. (2012) · Hormone Research in Paediatrics · doi:10.1159/000336003 · Cited by 70
Self-citationDamcott, C. M., Sack, P., & Shuldiner, A. R. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(03)00076-8 · Cited by 63
Chan, J. L., Bullen, J., Stoyneva, V., DePaoli, A. M., Addy, C., & Mantzoros, C. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1921 · Cited by 60
Self-citationRandomized double‐blind placebo‐controlled study of leptin administration after gastric bypass
Korner, J., Conroy, R., Febres, G., J. McMahon, D., Conwell, I., Karmally, W., & Aronne, L. J. (2013) · Obesity · doi:10.1002/oby.20433 · Cited by 60
Chan, J. L., Moschos, S. J., Bullen, J., Heist, K., Li, X., Kim, Y.-B., Kahn, B. B., & Mantzoros, C. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1823 · Cited by 56
Brennan, A. M., Li, T. Y., Kelesidis, I., Gavrila, A., Hu, F. B., & Mantzoros, C. S. (2007) · Diabetologia · doi:10.1007/s00125-007-0635-y · Cited by 54
Weight-dependent changes of immune system in adipose tissue: Importance of leptin
Caspar-Bauguil, S., Cousin, B., André, M., Nibbelink, M., Galinier, A., Periquet, B., Casteilla, L., & Pénicaud, L. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.023 · Cited by 52
(2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2019.07.012 · Cited by 46
Revisiting leptin’s role in obesity and weight loss
Ahima, R. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36284 · Cited by 43
Mutations in IRS4 are associated with central hypothyroidism
Heinen, C. A., de Vries, E. M., Alders, M., Bikker, H., Zwaveling-Soonawala, N., van den Akker, E. L. T., Bakker, B., Hoorweg-Nijman, G., Roelfsema, F., Hennekam, R. C., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-105113 · Cited by 38
Leptin as a Potential Treatment for Obesity: Progress to Date
Bell-Anderson, K. S., & Bryson, J. M. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403010-00002 · Cited by 36
Leptin and adiponectin: their role in diabetes.
Brennan, A. M., & Mantzoros, C. S. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0001-y · Cited by 32
Leptin administration does not prevent the bone mineral metabolism changes induced by weight loss
Conroy, R., Girotra, M., Shane, E., McMahon, D. J., Pavlovich, K. H., Leibel, R. L., Rosenbaum, M., & Korner, J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.02.010 · Cited by 31
Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives
Tchang, B. G., Shukla, A. P., & Aronne, L. J. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1052789 · Cited by 28
Ma, Y., Nenkov, M., Chen, Y., & Gaßler, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158352 · Cited by 28
Epidemiology of Obesity and Pharmacologic Treatment Options
Shettar, V., Patel, S., & Kidambi, S. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617713189 · Cited by 26
Licinio, J., Milane, M., Thakur, S., Whelan, F., Yildiz, B. O., Delibasi, T., de Miranda, P. B., Ozata, M., Bolu, E., DePaoli, A., et al. (2007) · Appetite · doi:10.1016/j.appet.2007.03.228 · Cited by 22
“A deficiency of leptin in both mice and human subjects is associated with massive obesity and hypogonadism (Farooqi et al., 1999, 2002; Licinio et al., 2004; Montague et al., 1997; Ozata et al., 1999; Strobel, Issad, Camoin, Ozata, & Strosberg, 1998; Zhang et al., 1994).”
BackgroundSelf-citationPapathanasiou, A. E., Nolen-Doerr, E., Farr, O. M., & Mantzoros, C. S. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0847 · Cited by 20
Rashad, N. M., Sayed, S. E., Sherif, M. H., & Sitohy, M. Z. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.05.027 · Cited by 15
Leptin for type 1 diabetes: coming onto stage to be (or not?)
Oral, E. A. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00797.x · Cited by 10
Metadata
- Authors
- Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., Lechler, R. I., DePaoli, A. M., & O’Rahilly, S.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-10-15
- Volume
- 110
- Issue
- 8
- Pages
- 1093-1103
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2098025594
- Cited by
- 1,320
- References
- 45
- FWCI
- 16.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.